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Abstract
Background  and  objectives:  Injection  pain  after  propofol  administration  is  common  and  may
disturb patients’  comfort.  The  aim  of  this  study  was  to  compare  effectiveness  of  intravenous
(iv) nitroglycerin,  lidocaine  and  metoprolol  applied  through  the  veins  on  the  dorsum  of  hand  or
antecubital vein  on  eliminating  propofol  injection  pain.
Method:  There  were  147  patients  and  they  were  grouped  according  to  the  analgesic  adminis-
tered. Metoprolol  (n  =  31,  Group  M),  lidocaine  (n  =  32,  Group  L)  and  nitroglycerin  (n  =  29,  Group
N) were  applied  through  iv  catheter  at  dorsum  hand  vein  or  antecubital  vein.  Pain  was  evalu-
ated by  4  point  scale  (0  --  no  pain,  1  --  light  pain,  2  --  mild  pain,  3  --  severe  pain)  in  5,  10,  15
and 20th  seconds.  ASA,  BMI,  patient  demographics,  education  level  and  the  effect  of  pathways
for injection  and  location  of  operations  were  analyzed  for  their  effect  on  total  pain  score.
Results: There  were  no  differences  between  the  groups  in  terms  of  total  pain  score  (p  =  0.981).
There were  no  differences  in  terms  of  total  pain  score  depending  on  ASA,  education  level,
location of  operation.  However,  lidocaine  was  more  effective  when  compared  with  metoprolol
(p =  0.015)  and  nitroglycerin  (p  =  0.001)  among  groups.  Although  neither  lidocaine  nor  metopro-
lol had  any  difference  on  pain  management  when  applied  from  antecubital  or  dorsal  hand  vein
(p >  0.05),  nitroglycerin  injection  from  antecubital  vein  had  demonstrated  statistically  lower
pain scores  (p  =  0.001).
Conclusion:  We  found  lidocaine  to  be  the  most  effective  analgesic  in  decreasing  propofol
related pain.  We  therefore  suggest  iv  lidocaine  for  alleviating  propofol  related  pain  at  opera-
tions.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  All  rights
reserved.∗ Corresponding author.
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PALAVRAS-CHAVE
Dor  no  local  da
injec¸ão de  propofol;
Lidocaína;
Nitroglicerina;
Metoprolol
Lidocaína  é  mais  eﬁcaz  do  que  metoprolol  e  nitroglicerina  para  o  alívio  da  dor
relacionada  à  injec¸ão de  propofol
Resumo
Justiﬁcativa  e  objetivos:  A  dor  no  local  da  injec¸ão  após  a  administrac¸ão  de  propofol  é  comum
e pode  causar  desconforto  nos  pacientes.  O  objetivo  deste  estudo  foi  comparar  a  eﬁcácia  de
nitroglicerina,  lidocaína  e  metoprolol,  aplicados  intravenosamente  através  de  veias  do  dorso
das mãos  ou  antecubitais,  para  eliminar  a  dor  causada  pela  injec¸ão  de  propofol.
Métodos: Foram  alocados  em  grupos  147  pacientes  de  acordo  com  o  analgésico  administrado:
metoprolol  (n  =  31,  Grupo  M),  lidocaína  (n  =  32,  Grupo  L)  e  nitroglicerina  (n  =  29,  Grupo  N).  Os
analgésicos  foram  aplicados  via  cateter  intravenoso  em  veia  do  dorso  da  mão  ou  antecubital.  A
dor foi  avaliada  com  uma  escala  de  quatro  pontos  (0  =  sem  dor,  1  =  dor  leve,  2  =  dor  moderada,
3 =  dor  intensa)  nos  segundos  cinco,  10,  15  e  20.  Os  dados  demográﬁcos  dos  pacientes,  estado
físico ASA,  IMC,  nível  de  escolaridade,  efeito  das  vias  de  injec¸ão  e  local  das  cirurgias  foram
analisados quanto  a  seus  efeitos  no  escore  total  de  dor.
Resultados:  Não  houve  diferenc¸a  entre  os  grupos  em  relac¸ão  ao  escore  total  de  dor  (p  =  0,981).
Não houve  diferenc¸a  no  escore  total  de  dor  em  relac¸ão  ao  estado  físico  ASA,  escolaridade  e  local
da cirurgia.  No  entanto,  lidocaína  foi  mais  eﬁcaz  em  comparac¸ão  com  metoprolol  (p  =  0,015)  e
nitroglicerina  (p  =  0,001),  na  comparac¸ão  entre  os  grupos.  Embora  lidocaína  e  metoprolol  não
tenham apresentado  diferenc¸a  no  tratamento  da  dor  quando  aplicados  em  veia  antecubital  ou
do dorso  da  mão  (p  >  0,05),  a  injec¸ão  de  nitroglicerina  em  veia  antecubital  apresentou  escores
de dor  estatisticamente  menores  (p  =  0,001).
Conclusão:  Lidocaína  mostrou-se  como  analgésico  mais  eﬁcaz  para  diminuir  a  dor  relacionada  à
injec¸ão de  propofol.  Sugerimos,  portanto,  lidocaína  IV  para  aliviar  a  dor  relacionada  à  injec¸ão
de propofol  em  operac¸ões.
©  2014  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Todos  os
direitos reservados.
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(Introduction
Propofol  is  an  intravenous  agent  which  is  often  preferred
for  same  day  surgery  and  has  short  period  effects.  Injection
pain  is  the  most  common  pain  and  one  of  the  adverse  effects
disturbing  patients’  comfort.  Injection  pain  incidence  rate  is
28--90%  for  adults  in  the  course  of  induction.1,2 Various  meth-
ods  and  drugs  are  tested  and  suggested  in  order  to  eliminate
injection  pain  caused  by  Propofol.  For  this  purpose,  some
studies  about  injection  speed  of  propofol,  temperature  of
propofol  and  the  vein  immensity  have  been  carried  out-
for  decreasing  pain.  Before  propofol  injection,  some  drugs
such  as  alfentanyl,  tramadol,  ketamine,  fentanyl,  morphine,
meperidine,  metoprolol  and  lidocaine  have  been  used  and
the  effectiveness  of  these  drugs  on  eliminating  injection
pain  has  been  tested.3--10
Although  there  are  many  researches  on  analgesic  effects
of  transdermal  nitroglycerin,  researches  about  effectiveness
of  nitroglycerin  on  eliminating  propofol  injection  pain  are
limited.2 The  aim  of  this  study  was  to  compare  effectiveness
of  intravenous  (iv)  nitroglycerin,  lidocaine  and  metoprolol
applied  through  the  veins  on  the  dorsum  of  hand  on  elimi-
nating  propofol  injection  pain  and  the  main  purpose  of  this
study  was  to  ensure  satisfaction  of  patients.
MethodsAfter  the  approval  of  patients  and  hospital  ethics  commit-
tee,  92  patients  at  the  ages  between  19  and  70  years  have
been  involved  in  the  randomized  double  blind  method  for
5
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ahe  research  planned  in  elective  conditions  at  HM  (Health
inistry)  Ankara  Training  and  Research  Hospital  in  accor-
ance  with  classiﬁcation  group  I  and  II  of  American  Society  of
nesthesiologist.  Hypertensive  patients,  diabetic  patients  or
atients  with  another  neuropathy,  patients  whose  body  mass
ndex  is  35  kg  m−2 or  above,  patients  with  allergy  to  these
rugs  and  with  Parkinson’s  disease,  with  thrombophlebitis
tory  have  been  excluded  from  this  research.
Routine  monitorization  including  ECG,  pulse  oximeter
nd  non-invasive  blood  pressure  have  been  applied  to
atients  who  have  undergone  intramuscular  (im)  preme-
ication  with  50  mg  meperidine  and  0.5  mg  atropine  after
ntravenous  line  (iv)  has  been  opened  at  the  dorsum  hand
ein  with  20  G  catheter.  Drugs  that  had  to  be  used  in  the
esearch  have  been  prepared  as  2  ml  in  total  and  numbered
y  a  researcher  independent  from  applicator.  After  venous
ischarge,  tourniquet  were  applied  to  arm  manually  for  45  s
nd  2  mg  metoprolol  to  31  patients  in  Group  M,  20  mg  lido-
aine  to  32  patients  in  Group  L,  0.25  mg  nitroglycerin  to  29
atients  in  Group  N  were  applied  through  iv  catheter  at
orsum  hand  vein.  After  tourniquet  was  loosened  up,  for
nesthesia  induction  2  mg/kg  propofol  was  injected  with  a
ow  of  2  ml  in  4  s.  The  administration  pathways  were  used
or  comparison  of  different  analgesics.
Pain  during  injection  was  evaluated  in  the  4  point  scale
0  --  no  pain,  1  --  light  pain,  2  --  mild  pain,  3  --  severe  pain)  at
,  10,  15  and  20th  seconds.  Patients  were  grouped  according
o  their  education  levels  as:  1  --  illiterate,  2  --  primary
chool,  3  --  secondary  school,  4  --  high  school,  5  --  university
nd  comparison  between  education  level  and  total  pain
3 A.  Goktug  et  al.
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Table  3  Number  of  patients  with  pain  when  Lidocaine
(n =  60)  was  injected  from  different  pathways.
Patients  with
pain  at
Group  E
(n  =  31)
Group  A
(n  =  29)
p
5th  sec  1  1  1.0
10th sec  6  6  0.101
15th sec  6  2  0.317
20th sec  3  3  0.228
A, antecubital area; E, back of hand.
Table  4  Number  of  patients  with  pain  when  Metoprolol
(n =  59)  was  injected  from  different  pathways.
Patients  with
pain  at
Group  E
(n  =  32)
Group  A
(n  =  27)
p
5th  sec  5  1  0.108
10th sec  3  2  0.463
15th sec  11  6  0.712
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core  was  done.  ASA  classiﬁcation  and  BMI  were  compared
ith  total  pain  score  using  the  abovementioned  scale.  In  the
re-operative  period,  after  propofol  induction  and  shortly
fter  intubation  5  min  later,  heart  rate  and  blood  pressure
ere  recorded.  The  ﬁfteenth  second  was  determined  as  the
ain  time  because  pain  frequency  was  observed  in  this  time
t  most.  In  that  case,  total  pain  score  instead  of  pain  score
easured  after  injection  is  more  effective  in  reﬂecting
atisfaction  of  patients  and  total  life  quality  score.  Location
f  operation  was  recorded  and  it  was  compared  with  total
ain  score.  The  location  was  numbered  as  0  --  head--neck
n  =  65),  1  --  thorax  (n  =  1),  2  --  upper  abdomen  (n  =  23),  3
- lower  abdomen  and  pelvis  (n  =  57),  4  --  extremity  and
araspinal  area  (n  =  31).  The  operation  at  thorax  was  not
ncluded  into  the  evaluation  because  there  was  only  one
atient.
ANOVA  variance  analysis  has  been  used  for  statistical
nalysis  of  the  results  and  demographic  data  and  2 test  has
een  used  for  comparison  of  groups  in  terms  of  pain.  Because
he  distribution  of  groups  was  normal,  pulse  oximetry,  arte-
ial  blood  pressure  and  heart  rate  measurements  among
roups  were  evaluated  according  to  the  variance  analysis
nd  Bonferroni  test.  A  p  <  0.05  was  considered  signiﬁcant.
esults
he  mean  age  of  the  patients  was  40  years  (range,
9--70  years)  and  the  mean  BMI  (body  mass  index)  was
5.34  ±  3.94  kg  m−2.  There  were  81  female  and  66  male
atients.  No  difference  was  found  among  the  groups  in  terms
f  demographical  data  such  as  age,  gender,  and  body  mass
ndex  (p  >  0.05).  Also  there  were  no  differences  in  terms
f  total  pain  score  depending  on  education  level  (p  >  0.05).
umber  of  patients  with  pain  according  to  time  intervals
hile  administration  of  analgesic  from  antecubital  area  and
orsum  of  hand  are  shown  in  Tables  1  and  2.  Also  number
f  patients  with  pain  when  lidocaine  (n  =  60),  metoprolol
Table  1  Number  of  patients  with  pain  according  to  time
intervals  while  administration  of  analgesic  from  back  of
hand.
Patients  with
pain  at
Group  L
(n  =  32)
Group  M
(n =  31)
Group  N
(n  =  29)
p
5th  sec  1  5  9  0.052
10th sec  6  9  18  0.023
15th sec  6  11  22  0.001
20th sec  3  14  22  0.001
L, Lidocaine; M, Metoprolol; N, Nitroglycerin.
Table  2  Number  of  patients  with  pain  according  to  time
intervals  while  administration  of  analgesic  from  antecubital
area.
Patients  with
pain  at
Group  L
(n  =  29)
Group  M
(n =  27)
Group  N
(n  =  29)
p
5th  sec  0  3  3  0.095
10th sec  0  5  4  0.261
15th sec  2  6  6  0.589
20th sec  0  4  10  0.011
L, Lidocaine; M, Metoprolol; N, Nitroglycerin.
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320th sec  14  4  0.071
A, antecubital area; E, back of hand.
n  = 59)  and  nitroglycerin  (n  =  58)  were  injected  from  dif-
erent  pathways  are  shown  in  Tables  3--5.  Although  neither
idocaine  nor  metoprolol  had  any  difference  on  pain  man-
gement  when  applied  from  antecubital  or  dorsal  hand  vein
p  >  0.05),  nitroglycerin  injection  from  antecubital  vein  had
emonstrated  statistically  lower  pain  scores  (p  =  0.001).
Total  pain  score  in  women  was  1.63  ±  2.89  and  total  pain
core  in  men  was  1.62  ±  2.44.  There  were  no  differences
etween  the  groups  in  terms  of  total  pain  score  (p  =  0.981).
hen  ASA  I  and  II  differences  are  taken  into  consideration,
here  were  no  signiﬁcant  differences  that  existed  among  the
roups  in  terms  of  total  pain  score  (ASA  I  =  134,  ASA  II  =  42)
p  =  0.661).  The  mean  pain  scores  at  ASA-I  and  ASA-II  patients
ere  1.63  ±  2.58  and  1.42  ±  2.82,  respectively.
The  total  pain  score  in  patients  who  have  undergone
xtremity  and  spinal  operations  has  been  measured  has  the
owest  rate  when  compared  with  other  locations.  There
ere  no  differences  among  other  areas  in  terms  of  pain
core.  Lidocaine  was  more  effective  when  compared  with
etoprolol  (p  =  0.015)  and  nitroglycerin  (p  =  0.001).  Further-
ore,  metoprolol  was  least  effective  when  compared  with
itroglycerin  in  terms  of  total  pain  score  (p  =  0.002).  In  total
ain  score  evaluation,  injections  in  antecubital  areas  were
etermined  to  be  more  advantageous  (p  =  0.001).  Total  pain
core  for  the  group  including  patients  with  BMI  lower  than
0,  with  normal  BMI  and  high  BMI  was  1.40  ±  2.48  kg  m−2.  For
Table  5  Number  of  patients  with  pain  when  Nitroglycerin
(n =  58)  was  injected  from  different  pathways.
Patients  with
pain  at
Group  E
(n  =  29)
Group  A
(n  =  29)
p
5th  sec  9  3  0.132
10th sec  18  4  0.001
15th sec  22  6  0.001
20th sec  22  10  0.014
A, antecubital area; E, back of hand.
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the  obese  group  (n  =  30),  the  score  was  2.70  ±  3.38  kg  m−2.
The  total  pain  score  for  obese  patients  was  statistically
higher  (p  =  0.016).
Discussion
Because  propofol  injection  causes  negative  experiences
about  anesthesia  and  restricts  comfort  of  patients,  some
studies  have  been  carried  out  to  ﬁnd  various  methods  and
tools.  The  propofol,  which  is  a  phenol,  causes  irritation  at
skin,  mucous  membranes  and  intima  of  the  veins.11 Direct
endotelial  irritation  of  nerve  endings  caused  by  propofol
causes  secretion  of  bradykinin  by  stimulating  kallikrein-kinin
cascade  system.  This  state  brings  out  injection  pain  by  caus-
ing  increase  in  contact  of  free  nerve  endings  and  liquid
phase  of  propofol  as  well  as  venous  dilatation  and  increase
of  permeability.  Every  drug  given  before  propofol  injection
alleviates  pain  by  diluting  liquid  phase  of  propofol  which
has  an  endothelium  irritant  effect.  It  is  thought  that  pain  is
related  to  concentration  of  liquid  phase  although  there  is  no
certain  information  about  its  mechanism.12
Pain  caused  by  propofol  injection  emerges  at  early  and
late  periods.  Pain  at  early  period  is  related  to  direct  effect  of
propofol  and  pain  at  late  period  is  related  to  local  secretion
of  kininogens.  At  the  present  day,  the  most  common  agent
used  for  alleviating  propofol  injection  pain  is  lidocaine.10
Scott  et  al.  stated  that  lidocaine  alleviates  pain  by  sta-
bilizing  kinincascade  while  Eriksson  stated  that  this  agent
alleviates  pain  by  decreasing  pH  and  concentration.13,14
Propofol,  by  an  indirect  action  on  the  endothelium,  acti-
vates  the  kallikrein-kinin  system  and  releases  bradykinin,
thereby  producing  venous  dilation  and  hyper  permeability,
which  increases  the  contact  between  the  aqueous  phase
of  propofol  and  free  nerve  endings,  resulting  in  pain  on
injection.15 Propofol,  when  drawn  up  in  a  disposable  syringe,
may  lead  to  formation  of  irritants  and  propofol  pain.  It  has
been  conﬁrmed  that  propofol  strips  the  silicone  lubricant
from  the  inside  barrel  of  plastic  syringes.  A  reduction  in
propofol  pain  by  cooling  it  to  4 ◦C  and  minimizing  propofol
injection  pain  is  an  important  clinical  goal  because  it  may
inﬂuence  the  patient’s  perception  of  quality  and  acceptabil-
ity  of  anesthesia.  In  conclusion,  pretreatment  with  lidocaine
40  mg,  thiopental  0.25  mg/kg,  and  thiopentone  0.5  mg/kg
after  manual  venous  occlusion  attenuates  propofol  pain.
However,  pretreatment  with  thiopental  0.5  mg/kg  after
manual  venous  occlusion  was  the  most  effective  in  atten-
uating  propofol-induced  pain.  We  therefore  suggest  routine
pretreatment  with  thiopental  0.5  mg/kg  along  with  manual
venous  occlusion  for  1  min  for  prevention  of  pain  associated
with  propofol  injection.
Nitroglycerin  is  a  commonly  used  agent  in  treatment  of
ischemic  heart  disease.16 Nitroglycerin,  a  strong  vasodila-
tor,  is  metabolized  as  nitric  oxide  (NO)  in  cells.  NO  causes
intracellular  concentration  of  cylicguanosine  monophos-
phate  (cGMP)  which  leads  to  pain  modulation  in  central  and
peripheral  nervous  system.17 NO,  applied  topically,  shows
anti-inﬂammatory  and  analgesic  effect  by  blocking  neuro-
genic  component  of  inﬂammatory  edema  and  hyper  allergy
and  inhibits  adhesion  of  neutrophils  to  endothelium  sur-
face.  The  fact  that  transdermal  nitroglycerin  is  effective
in  pain  treatment  has  been  proven  with  various  studies.18
C
T341
ransdermal  nitroglycerin  shows  vasodilation  effect  and
nalgesic  effect  by  increasing  diffusion  of  local  anesthet-
cs  and  arrival  to  nerve  trunk.19 Nitroglycerin  pomade  shows
nalgesic  effect  and  vasodilator  effect  in  vein  sizes.20
Nitroglycerin  is  metabolized  to  nitric  oxide  (NO)  in  the
ell.17,21 NO  causes  increase  in  the  intracellular  concen-
ration  of,  which  produces  pain  modulation  in  the  central
nd  peripheral  nervous  system.  NO  generators  also  induce
nti-inﬂammatory  effects  and  analgesia  by  blocking  hyper-
lgesia  and  the  neurogenic  component  of  inﬂammatory
dema  by  topical  application.22 Another  possible  mech-
nism  includes  an  analgesic  effect  through  the  direct
timulation  of  peripheral  ﬁbers  mimicking  the  actions
f  locally  applied  acetylcholine.23 Mechanisms  mentioned
bove,  or  their  combinations,  might  contribute  to  the
nalgesic  effects  of  nitroglycerin  added  to  lidocaine  in
ntravenous  regional  anesthesia.  The  clinical  efﬁcacy  of
ransdermal  nitroglycerin  for  acute  pain  relief  has  been
ocumented  in  several  studies.23 Nitroglycerin  was  found
o  be  useful  for  the  treatment  of  shoulder  pain  and
hrombophlebitis  and  for  enhancing  the  effect  of  spinal
ufentanil  or  neostigmine.22 Lauretti  et  al.  also  showed  that
elivery  of  NO  donors  (transdermal  nitroglycerin)  together
ith.24
Opioids  may  be  of  signiﬁcant  beneﬁt  in  cancer  pain  man-
gement,  delaying  morphine  tolerance  and  decreasing  the
requency  of  adverse  effects  related  to  large  doses  of  opioid.
t  has  been  concluded  that  0.25  nitroglycerin  is  less  effective
n  alleviating  propofol  injection  pain  compared  to  lidocaine
nd  metroprolol.  We  have  concluded  that  higher  pain  rates
n  obese  patients  stems  from  standard  amount  of  premedi-
ation.  In  other  words,  amount  of  drugs  per  kilo  is  lower  in
bese  patients
Nitroglycerin  is  metabolized  to  nitric  oxide  (NO)  in  the
ell.17,21 NO  causes  an  increase  in  the  intracellular  concen-
ration  of  cyclic  guanosine  monophosphate,  which  produces
ain  modulation  in  the  central  and  peripheral  nervous
ystem.24,17 NO  generators  also  induce  anti-inﬂammatory
ffects  and  analgesia  by  blocking  hyperalgesia  and  the
eurogenic  component  of  inﬂammatory  edema  by  top-
cal  application.22 Another  possible  mechanism  includes
n  analgesic  effect  through  the  direct  stimulation  of
eripheral  ﬁbers  mimicking  the  actions  of  locally  applied
cetylcholine.17,23 As¸ık  et  al.  have  stated  that  pre-treatment
ith  (iv)  metoprolol  is  as  effective  as  lidocaine  in  alleviating
ropofol  injection  pain.10
In  conclusion,  we  found  Lidocaine  to  be  the  most
ffective  analgesic  in  decreasing  propofol  related  pain.
e  therefore  suggest  iv  Lidocaine  for  alleviating  propofol
elated  pain  at  operations.  However,  nitroglycerin  injection
nto  antecubital  veins  has  yielded  lower  levels  of  propofol
elated  pain.  Also  we  have  conﬁrmed  that  injection  pain
s  not  related  to  gender  and  education  level.  Furthermore,
e  found  that  injection  pain  is  related  to  obesity  and  total
ain  score  in  obese  patients  was  statistically  higher.  For
valuation  of  total  pain  score,  antecubital  area  is  more
dvantageous  than  the  dorsum  of  the  hand.onﬂict of interest
he  authors  declare  no  conﬂicts  of  interest
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